LIFR protein suppresses breast cancer metastasis
MD Anderson-led team's preclinical study identifies new prognostic marker for survival
MD Anderson News Release 09/24/12
A receptor protein suppresses local invasion and metastasis of breast cancer cells, the most lethal aspect of the disease, according to a research team headed by scientists from The University of Texas MD Anderson Cancer Center.
Reporting in Nature Medicine, the team described using...
UT MD Anderson's Pam Redden honored for excellence in administration
Rogers Award recognizes Redden's expertise in patient-focused facilities
MD Anderson News Release 07/24/12
Pam...
UT MD Anderson Cancer Center Launches Unprecedented Moon Shots Program
Effort sets new bar for eradicating cancer; Goal to significantly increase patient survival during the next decade
MD Anderson...
Drug combination against NRAS-mutant melanoma discovered
MD Anderson News Release 09/17/12
A new study published online in Nature Medicine, led by scientists at The University of Texas MD Anderson Cancer Center, describes the discovery of a novel drug combination aimed at a subset of melanoma patients who currently have no effective therapeutic options.
Melanoma patients have different responses to therapy, depending on what genes are mutated in their tumors. About half of melanomas...
UT MD Anderson fun run goes dark to highlight importance of skin cancer prevention
MD Anderson News Release 09/12/12
Runners and walkers will hit the streets for the fifth annual AIM for a Cure Melanoma Walk and Fun...
MD Anderson Hosts Free Prostate Health Conference on Sept. 22
MD Anderson News Release 09/05/12
The University of Texas MD Anderson Cancer Center is hosting its 5th annual Prostate Health Conference...
UT MD Anderson study finds biologic therapies for rheumatoid arthritis not associated with increased cancer risk
Largest systematic review provides the most current information on class of drugs available to patients
MD Anderson News...